Dudediligence.

Lantern Pharma Inc

LTRNNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

12.8M

on 2026-06-30, from 10.8M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

5M10MMar2024JunSepDecMar2025JunSepDecMar2026Jun$2.06

Newest

S-3 of 2024-05-24. Not read yet. S-3 ↗

5 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

2.1 quarters

$7.4M on 2026-06-30 ÷ $3.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-28Public offering incl. 2.20M pre-funded3,669,725$1.09$4.0M424B5 ↗
2026-05-12Public offering incl. 0.68M pre-funded2,135,923$2.06$4.4M424B5 ↗